Theragen Inc

Theragen, Inc. is a medical technology company developing and manufacturing non-invasive electrical stimulation devices for orthopedic and spine fusion therapy. The flagship product, ActaStim® Bone Growth Stimulator System, is an FDA-cleared device designed as an adjunct treatment for lumbar spinal fusion surgery. Using capacitive coupling technology, the system delivers electrical stimulation to promote bone growth and healing by facilitating calcium ion uptake at the fusion site. The portable, wearable ActaStim-S device integrates digital health capabilities providing patients and providers with actionable recovery insights and remote monitoring. Theragen holds multiple patents in neurotechnology and bone health, has managed care coverage for over 150 million U.S. residents, and is recognized by the North American Spine Society (NASS) as a recommended bone growth stimulation option post-fusion.